Browse by all authors Browse By Author Name - Taylor,+S.

Browse Results (71 results found)

Subscribe to the RSS feed for this result setSubscribe to the RSS feed for this result set

Page 1 of 2

Result Pages:    1 2  next › last »

  Abstract Views File Downloads Thomson Reuters Web of Science Citation Count Scopus Citation Count Altmetric Score
Bulmer, A.C., Coombes, J.S., Blanchfield, J.T., Toth, I. and Taylor, S.M. (2008). Absorption and pharmacokinetics of bilirubin and biliverdin administration in the rat. In: A. Butt, Proceedings of the Australian Health and Medical Research Congress 2008. Australian Health and Medical Research Congress, Brisbane, (404). 16 - 21 November, 2008. 252  
Emmerton, L. M., Benrimoj, S. I., Williams, K., Taylor, R. J., Gadiel, D., Taylor, S., Carroll, P., Gilbert, A., Wolk, J. and Raffaele, C. (2003). A conceptual approach for measurement of clinical benefits associated with pharmacist only and pharmacy medicines in Australia: Work in progress. In: Developing a new contract between pharmacy and society (risk management and improving outcomes). 63rd International Congress of International Pharmaceutical Federation, Sydney, NSW, Australia, (87-87). 4-9 September, 2003. 65  
Emmerton, L. M., Benrimoj, S. I., Williams, K., Taylor, R. J., Gadiel, D., Taylor, S., Carroll, P., Gilbert, A., Wolk, J., Raffaele, C. and Bayari, C. (2003). A conceptual approach for measurement of clinical benefits associated with pharmacist only and pharmacy medicines in Australia: Work in progress. In: Making it better; encouraging health research and innovation. Annual Queensland Health and Medical Scientific Meeting 2003, Brisbane, (1-1). 25-26 November, 2003. 75  
Williams, K., Benrimoj, S. I., Emmerton, L. M., Taylor, R. J., Gadiel, D., Taylor, S., Carroll, P., Gilbert, A., Raffaele, C. and Bayari, C. (2003). A conceptual approach for measurement of clinical benefits associated with pharmacist only and pharmacy medicines in Australia: Work in progress. In: Integrating research into practice. Annual Conference of Australasian Pharmaceutical Science Association 2003, Bondi Beach, NSW, (132-132). 3-5 December, 2003. 61  
Woodruff, T. M., Proctor, L. M., Shiels, I. A. and Taylor, S. M. (2004). A cyclic peptide, C5a receptor antagonist analogue confers increased potency in a model of inflammatory bowel disease in rats. In: Molecular immunology: Abstracts of the 20th International Complement Workshop. 20th International Complement Workshop, Honolulu, Hawaii, (326-326). 13-18 June, 2004. doi:10.1016/j.molimm.2004.03.002 278   1 0
Shiels, I. A., Bowler, S. D. and Taylor, S. M. (1995) Airway smooth muscle proliferation in asthma: The potential of vascular leakage to contribute to pathogenesis. Medical Hypothesis, 45 1: 37-40. doi:10.1016/0306-9877(95)90198-1 49   17 Cited 17 times in Scopus17 0
Woodruff, T. M., Shiels, I. A., Fairlie, D. and Taylor, S. M. (2001). A new C5a receptor antagonist inhibits monoarticular arthritis in the rat. In: Proceedings of the Complement Associated Diseases, Animal Models and Therapeutics Workshop. Complement Assoc. Diseases, Animal Models & Ther. Workshop, Santorini, Greece, (37-37). 10-14 October, 2001. 77  
Strachan, A. J., Woodruff, T.M., Haaima, G., Fairlie, D. P. and Taylor, S. M. (2000) A new small molecule C5a receptor antagonist inhibits the reverse-passive arthus reaction and endotoxic shock in rats. Journal of Immunology, 164 4: 6560-6565. 115   80
Shiels, I. A., Sanderson, S. D. and Taylor, S. M. (1999) Arterially perfused eye model of uveitis. Australian Veterinary Journal, 77 2: 100-104. doi:10.1111/j.1751-0813.1999.tb11677.x 88   6 0
Arumugam, T. V., Shiels, I. A., Strachan, A. J., Abbenante, G., Fairlie, D. P. and Taylor, S. M. (2003) A small molecule C5a receptor antagonist protects kidneys from ischemia/reperfusion injury in rats. Kidney International, 63 1: 134-142. doi:10.1046/j.1523-1755.2003.00737.x 115   100 Cited 107 times in Scopus107 0
Mirkovic, S., Seymour, A. M. L., Fenning, A., Strachan, A., Margolin, S. B., Taylor, S. M. and Brown, L. (2002) Attenuation of cardiac fibrosis by pirfenidone and amiloride in DOCA-salt hypertensive rats. British Journal of Pharmacology, 135 4: 961-968. doi:10.1038/sj.bjp.0704539 69   49 Cited 54 times in Scopus54 0
Otlowski, M.F., Taylor, S. D. and Barlow-Stewart, K (2002) Australian empirical study into genetic discrimination. Eubios Journal of Asian and International Bioethics, 12 5: 164-167. 54  
Bulmer, A. C., Coombes, J. S., Blanchfield, J. T., Toth, I., Fassett, R. G. and Taylor, S. M. (2011) Bile pigment phamacokinetics and absorption in the rat: Therapeutic potential for enteral administration. British Journal of Pharmacology, 164 7: 1857-1870. doi:10.1111/j.1476-5381.2011.01413.x 82   14 Cited 15 times in Scopus15 0
Taylor, S. D. (2002) Book review of 'The New Genetics & the Public's Health' by A. Petersen & R. Bunton (Eds). New Genetics and Society, 21 3: 351-352. doi:10.1080/14636770216007 40   0
Lingard, B., Taylor, S. and Rawolle, S. (2005) Bourdieu and the study of educational policy: introduction. Journal of Education Policy, 20 6: 663-669. doi:10.1080/02680930500238838 68   3 Cited 8 times in Scopus8 0
Craft, C., Murray, D., Rowley, D., Ryan, M. and Taylor, S. D. (2002) Breaking into the Game: A mentoring program in research writing and publication. Advances in Social Work Education, 4 1: 15-22. 52  
Costantini, K. J., Coulthard, L. G. J., Lor, Mary, Woodruff, T. M., Callaway, L. K., Finnell, R. H. and Taylor, S. M. (2010). C5aR protects against folate-deficiency induced neural tube defects in mice. In: Berhane Ghebrehiwet, Ellinor I. Peerschke and Richard R. Kew, Molecular Immunology. Proceedings of: XXIII International Complement Workshop. XXIII International Complement Workshop, New York, NY, U.S.A., (2254-2254). 1-5 August 2010. doi:10.1016/j.molimm.2010.05.169 67   0 0
Levick, S., Taylor, S. M., Fairlie, D. and Brown, L. C. (2004). Cardiovascular structural and functional adaptations to group IIAsPLA2 inhibition. In: R. A. Walsh and A. Smisek, XV111 World Congress of the International Society for Heart Research. 2004 ISHR World Congress, Brisbane, Australia, (272-273). 7-11/8/04. 49   0
Shiels, I. A., Taylor, S. M. and Fairlie, D. P. (2000) Cell phenotype as a target of drug therapy in chronic inflammatory diseases. Medical Hypotheses, 54 2: 193-197. doi:10.1054/mehy.1999.0017 55   7 0
Taylor, S. M. and Bennett, M. B. (2008) Cephalopod dietary specialization and ontogenetic partitioning of the Australian weasel shark Hemigaleus australiensis White, Last & Compagno. Journal of Fish Biology, 72 4: 917-936. doi:10.1111/j.1095-8649.2007.01771.x 108   12 Cited 12 times in Scopus12 0
Kalo, P., Seres, A., Taylor, S. A., Jakab, J., Kevei, Z., Kereszt, A., Endre, G., Ellis, T. H. N. and Kiss, G. B. (2004) Comparative mapping between Medicago sativa and Pisum sativum. Molecular Genetics And Genomics, 272 3: 235-246. doi:10.1007/s00438-004-1055-z 105   91 Cited 90 times in Scopus90 0
Coulthard, L. G. J., Costantini, K. J., Lor, Mary, Simmons, D., Taylor, S. M. and Woodruff, T. M. (2010). Complement expression in mice throughout neural tube closure. In: Berhane Ghebrehiwet, Ellinor I. Peerschke and Richard R. Kew, Molecular Immunology. Proceedings of: XXIII International Complement Workshop. XXIII International Complement Workshop, New York, NY, U.S.A., (2251-2251). 1-5 August 2010. doi:10.1016/j.molimm.2010.05.163 56   0 0
Woodruff, T.M., Proctor, L.M., Strachan, A.J. and Taylor, S.M. (2006) Complement factor 5a as a therapeutic target. Drugs of The Future, 31 4: 325-334. doi:10.1358/dof.2006.031.04.980656 80   7 Cited 7 times in Scopus7 0
Taylor, S., Treloar, S., Barlow-Stewart, K., Otlowski, M. and Stranger, M. (2007). Consumer experiences and predictive genetic testing. In Stranger, M. (Ed.), Human Biotechnology & Public Trust: Trends, Perceptions and Regulation (pp. 149-166) University of Tasmania: Centre for Law and Genetics. 58  
Bornaghi, L., Dekany, G., Drinnan, N. B., Taylor, S., Toth, I. and West, M. L. (2006) Dde as a protecting group for carbohydrate synthesis. Journal of Carbohydrate Chemistry, 25 1: 1-18. doi:10.1080/07328300500388685 143   4 Cited 4 times in Scopus4 0
Wong, A., Taylor, S. M. and Fairlie, D. (1999) Development of C5a receptor antagonists. Investigational Drugs, 2 7: 686-693. 49  
Denny, K. J., Crane, J. W., Taylor, S. M. and Noakes, P. G. (2006). Differential localization and expression of complement in a rat model of motor neuron disease. In: ComBio2006, Brisbane Convention & Exhibition Centre, Brisbane, Qld, Aust, (). 24-28 September 2006. 64 40
Taylor, S. M. and Fairlie, D. (2005). Discovery of Potent Cyclic Antagonists of Human C5a Receptors. In I. Morikis and J Lambris (Ed.), Structural Biology of the Complement System (pp. 341-362) New York: CRC Press, Taylor and Francis. 44  
Manthey, H., Taylor, S., Shiels, I. and Rolfe, B. (2007). Does C5a have a role in the pathophysiology of atherosclerosis?. In: W.-C. Song and X.-M. Gao, Molecular Immunology: Proceedings XXI International Complement Workshop. XXI International Complement Workshop, Beijing, China, (213-213). 22-26 October 2006. doi:10.1016/j.molimm.2006.07.154 122   0 0
Proctor, L.M., Woodruff, T.M., Pazckowski, N.P., Monk, P.N. and Taylor, S.M. (2004). Dual C3a/C5a receptor agonism by a C5a C-terminal analogue decapeptide. In: Molecular Immunology: Abstracts of the 20th International Complement Workshop. 20th International Complement Workshop, Honolulu, Hawaii, (297-297). 13-18 June, 2004. doi:10.1016/j.molimm.2004.03.002 97   0 0
Woodruff, T. M., Lee, J. D., Taylor, S. M. and Noakes, P. G. (2010). Dysregulation of the complement system in neurodegenerative disease. In: Berhane Ghebrehiwet, Ellinor I. Peerschke and Richard R. Kew, Molecular Immunology. Proceedings of: XXIII International Complement Workshop. XXIII International Complement Workshop, New York, NY, U.S.A., (2270-2270). 1-5 August 2010. doi:10.1016/j.molimm.2010.05.215 64   0 0
Memmott, P. C., Channells, G., Go-Sam, C., Stacy, R., Spring, F., Taylor, S., Chambers, C. and Thomson, L. (2004) Evaluation report of National Indigenous Family Violence Grants Programme of the Office of the Status of Women The University of Qld, St Lucia, Qld: Paul Memmott and Associates in association with AERC 116  
Otlowski, M. F., Taylor, S. D. and Barlow-Stewart, K. K. (2003) Genetic discrimination: Too few data. European Journal of Human Genetics, 11 1: 1-2. doi:10.1038/sj.ejhg.5200910 31   11 Cited 10 times in Scopus10 0
Stocks, S. Z., Shiels, I. A. and Taylor, S. M. (1999) Homologous serum-stimulated fibronectin synthesis in human retinal pigmented epithelial cells. Australian and New Zealand Journal of Ophthalmology, 27 8: 247-249. doi:10.1046/j.1440-1606.1999.00199.x 38   3 Cited 4 times in Scopus4 0
Mills, A. K., Wright, S., Taylor, S. M. and McCormack, J. G. (1999) Hypercalcaemia caused by Pneumocystis carini pneumonia while in leukaemic remission.. Australia and New Zealand Journal of Medicine, 29 1: 102-103. doi:10.1111/j.1445-5994.1999.tb01604.x 90   5 0
Woodruff, T. M., Pollitt, S., Proctor, L. M., Stocks, S. Z., Manthey, H. D., Williams, H. M., Mahadevan, I. B., Shiels, I. A. and Taylor, S. M. (2005) Increased potency of a novel complement factor 5a receptor antagonist in a rat model of inflammatory bowel disease. Journal of Pharmacology And Experimental Therapeutics, 314 2: 811-817. doi:10.1124/jpet.105.086835 66   31 Cited 32 times in Scopus32 0
Ulrich, J. T., Cieplak, W, Paczkowski, N., Taylor, S. M. and Sanderson, S. D. (2000) Induction of an antigen-specific CTL response by a conformationally biased agonist of human C5a anaphylatoxin as a molecular adjuvant. Journal of Immunology, 164 3: 5492-5498. 53   20
Bulmer, A. C., Coombes, J. S., Blanchfield, J. T., Toth, I., Fassett, R. G. and Taylor, S. M. (2008). Intestinal and intraperitoneal absorption and bioavailability of the antioxidants unconjugated bilirubin, biliverdin and bilirubin ditaurate in the rat. In: Free Radical Research: SFRR-E Berlin. SFRR-E Berlin, Berlin, Germany, (S71-S71). 5-9 July, 2008. doi:10.1080/10715760802207914 155   0 0
Taylor, S., Treloar, S., Barlow-Stewart, K., Stranger, M and Otlowski, M. (2008) Investigating genetic discrimination in Australia: a large-scale survey of clinical genetics clients. Clinical Genetics, 74 1: 20-30. doi:10.1111/j.1399-0004.2008.01016.x 116   35 Cited 41 times in Scopus41 0
Taylor, S.D., Otlowski, M. F., Barlow-Stewart, K. K., Treloar, S. A., Stranger, M. and Chenoweth, K. (2004) Investigating genetic discrimination in Australia: Opportunities and challenges in the early stages. New Genetics And Society, 23 2: 225-239. doi:10.1080/1463677042000237053 32   16 Cited 18 times in Scopus18 0
Taylor, S., Treloar, S., Barlow-Stewart, K., Otlowski, M. and Stranger, M. (2007) Investigating genetic discrimination in Australia: Perceptions and experiences of Clinical Genetics Service clients regarding coercion to test, insurance and employment. Australian Journal of Emerging Technologies and Society, 5 2: 63-83. 74   Cited 10 times in Scopus10
Otlowski, M., Barlow-Stewart, K., Taylor, S., Stranger, M. and Treloar, S. (2007) Investigating genetic discrimination in the Australian life insurance sector: The use of genetic test results in underwriting, 1999-2003. Journal of Law and Medicine, 14 3: 367-396. 65   Cited 13 times in Scopus13
Hanson, G. R., Taylor, S. W., Grillo, V. A., Cashion, J. D., Brown, L. J., Wang, D. M., Gahan, L. R. and Hawkins, C. J. (1994). Iron(III) binding studies of ferreascidin and their implication for the protein's proposed biological function. In: Programme and Abstracts: Third International Symposium on Applied Bioinorganic Chemistry. ISABC-3: 3rd International Symposium on Applied Bioinorganic Chemistry, Fremantle, WA, Australia, (). 11-16 December 1994. 50  
Finch, A., Wong, A. K., Paczkowski, N. J., Wadi, S. K., Craik, D. J., Fairlie, D. and Taylor, S. M. (1999) Low-molecular-weight peptidic and cyclic antagonists of the receptor for the complement factor C5a. Journal of Medicinal Chemistry, 42 6: 1965-1974. doi:10.1021/jm9806594 60   152 Cited 158 times in Scopus158 0
Otlowski, M.F., Taylor, S. D. and Barlow, C. (2002) Major study commencing into genetic discrimination in Australia. Journal of Law and Medicine, 10 August: 41-48. 42  
Cain, S. A., Woodruff, T. M., Taylor, S. M., Fairlie, D. P., Sanderson, S. D. and Monk, P. N. (2001) Modulation of ligand selectivity by mutation of the first extracellular loop of the human C5a receptor. Biochemical Pharmacology, 61 12: 1571-1579. doi:10.1016/S0006-2952(01)00608-6 168   13 Cited 13 times in Scopus13 0
Breivik, T., Gundersen, Y., Gjermo, P., Taylor, S. M., Woodruff, T. M. and Opstad, P. K. (2011) Oral treatment with complement factor C5a receptor (CD88) antagonists inhibits experimental periodontitis in rats. Journal of Periodontal Research, 46 6: 643-647. doi:10.1111/j.1600-0765.2011.01383.x 33   7 Cited 6 times in Scopus6 0
Zhang, S., Shiels, I. A., Ambler, J. S. and Taylor, S. M. (1998). Pirfenidone reduces fibronectin synthesis by cultured human retinal pigment epithelial cells. In: Australian and New Zealand Journal of Ophthalmology: Australian Ophthalmic Visual Science Meeting 1997. Australian Ophthalmic Visual Science Meeting 1997, Canberra, Australia, (S74-S76). 6-7 December 1997. doi:10.1111/j.1442-9071.1998.tb01380.x 118   13 0
Taylor, S. D. (2003) Predictive testing for an individual at 25% risk for Huntington's disease: Present conundrums, future challenges. Journal of Futures Studies, 7 4: 27-36. 51  
Arumugum, T.V., Shiels, I. A., Fairlie, D. and Taylor, S. M. (2001). Prevention of ischemia/reperfusion injuries in rats by a new small molecule C5a receptor antagonist. In: Proceedings of the Complement Associated Diseases, Animal Models, and Therapeutics Workshop. Complement Associated Diseases, Animal Models and Ther. W/shop, Santorini, Greece, (47-47). 10-14 October 2001. 38  

Page 1 of 2

Result Pages:    1 2  next › last »